ivermectin 12mg, with its active ingredient ivermectin, has been investigated for its potential to treat parasitic infections in laboratory animals used in pharmaceutical research. By ensuring the health and welfare of research animals, ivermectin contributes to the reliability and ethical conduct of preclinical studies for drug development.